Conference also to feature talks by three other Hutch scientists:

• Dr. Mark Roth on new methods for diagnosing lupus
• Dr. Jerald Radich on detecting the 'genetic fingerprints' of leukemia
• Dr. Dusty Miller on 'interrogating the human genome'

Dr. Lee Hartwell, president and director of the Fred Hutchinson Cancer Research Center, will join four other biotechnology leaders in addressing such questions during a symposium entitled "Visions of Biotechnology Pioneers" from 8 to 9:30 a.m. Monday, May 17. The symposium is part of BIO '99, an international biotechnology meeting and exhibition to be held May 16 to 20 at the Washington State Convention and Trade Center in Seattle.

Hartwell is a recipient of the prestigious Albert Lasker Basic Medical Research Award and is internationally known for his work in yeast genetics.

Joining Hartwell in addressing the future of biotechnology will be the University of Washington's Dr. Edwin Krebs, 1992 recipient of the Nobel Prize for Physiology in Medicine; Dr. George Rathmann, founder and former president and CEO of Amgen; the University of British Columbia's Michael Smith, 1993 Nobel Prize recipient in chemistry; and Dr. Kathryn Zoon, director of the Center for Biologics Evaluation and Research at the U.S. Food and Drug Administration. The symposium will be moderated by KCTS-TV business analyst Barry Mitzman.

From 9:30 to 11:15 a.m. the same day, three Hutchinson Center scientists will participate in a technology-transfer forum that will present leading candidate technologies from 20 top research institutions.

Presenting from the Hutch will be:

• Dr. Mark Roth of the Basic Sciences Division, who will speak about a new, antigen-based method for diagnosing sys
  '"/>